In European Pharmacopoeia monographs, the acceptance criteria for related substances have so far usually been expressed in terms of comparison of peak areas (“… not more than the area of the principal peak in the chromatogram obtained with reference solution …”), which, strictly speaking, leads to a pass/fail decision but not to a true quantitative test result.